Rekah Pharmaceutical Industry Ltd Cash Flow Reinvestment Rate
Rekah Pharmaceutical Industry Ltd cash flow reinvestment rate. Rekah Pharmaceutical Industry Ltd (REKA) has a Cash Flow Reinvestment Rate of 0.04x as of June 2026, reinvesting ILA495.00K (capex ILA495.00K ) from operating cash flow of ILA13.82 Million. Explore Rekah Pharmaceutical Industry Ltd (REKA) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Rekah Pharmaceutical Industry Ltd (2002–2025)
Cash flow reinvestment rate of Rekah Pharmaceutical Industry Ltd from 2002 to 2025. Historical reinvestment intensity for Rekah Pharmaceutical Industry Ltd across 21 annual periods. Explore REKA capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Rekah Pharmaceutical Industry Ltd Cash Flow Reinvestment Rate by Year (2002–2025)
Rekah Pharmaceutical Industry Ltd cash flow reinvestment rate by year from 2002 to 2025. Year-by-year capital reinvestment analysis for Rekah Pharmaceutical Industry Ltd. For the full cash flow conversion analysis, see REKA cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (ILA) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.58x | ILA7.47 Million | ILA12.95 Million | ILA7.03 Million | ▲ +73.1% |
| 2024 | 0.33x | ILA8.85 Million | ILA26.54 Million | ILA8.70 Million | ▼ -18.3% |
| 2023 | 0.41x | ILA11.57 Million | ILA28.35 Million | ILA11.49 Million | ▼ -24.0% |
| 2022 | 0.54x | ILA20.93 Million | ILA39.00 Million | ILA7.48 Million | ▼ -35.6% |
| 2021 | 0.83x | ILA17.65 Million | ILA21.17 Million | ILA13.99 Million | ▼ -58.2% |
| 2020 | 1.99x | ILA22.49 Million | ILA11.28 Million | ILA18.84 Million | ▲ +37.8% |
| 2019 | 1.45x | ILA49.05 Million | ILA33.91 Million | ILA45.40 Million | ▲ +60.1% |
| 2018 | 0.90x | ILA15.61 Million | ILA17.28 Million | ILA15.18 Million | ▲ +20.9% |
| 2017 | 0.75x | ILA17.77 Million | ILA23.80 Million | ILA16.48 Million | ▼ -37.0% |
| 2016 | 1.19x | ILA27.08 Million | ILA22.82 Million | ILA13.44 Million | ▼ -54.1% |
| 2015 | 2.59x | ILA15.02 Million | ILA5.81 Million | ILA13.15 Million | ▼ -84.2% |
| 2014 | 16.32x | ILA21.71 Million | ILA1.33 Million | ILA19.27 Million | ▲ +4180.1% |
| 2013 | 0.38x | ILA4.46 Million | ILA11.71 Million | ILA4.38 Million | ▼ -44.9% |
| 2012 | 0.69x | ILA9.82 Million | ILA14.18 Million | ILA9.82 Million | ▼ -40.8% |
| 2010 | 1.17x | ILA7.87 Million | ILA6.73 Million | ILA7.87 Million | ▲ +226.1% |
| 2009 | 0.36x | ILA9.33 Million | ILA26.03 Million | ILA9.33 Million | ▼ -78.0% |
| 2008 | 1.63x | ILA10.73 Million | ILA6.57 Million | ILA10.73 Million | ▲ +285.0% |
| 2007 | 0.42x | ILA5.28 Million | ILA12.45 Million | ILA5.28 Million | ▼ -74.4% |
| 2005 | 1.66x | ILA7.09 Million | ILA4.27 Million | ILA7.09 Million | ▲ +530.7% |
| 2004 | 0.26x | ILA4.70 Million | ILA17.87 Million | ILA4.70 Million | ▲ +20.9% |
| 2002 | 0.22x | ILA2.44 Million | ILA11.21 Million | ILA2.44 Million | — |